| Not Yet Recruiting | Wet Heparinized Suction for Abdominal Cancer NCT05041335 | H. Lee Moffitt Cancer Center and Research Institute | N/A |
| Active Not Recruiting | LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA AS PRECISION MEDICINE IN GASTROINT NCT06940778 | Hospital do Coracao | — |
| Recruiting | Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients NCT06046794 | Institut Paoli-Calmettes | N/A |
| Not Yet Recruiting | Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Soli NCT05361954 | Sorrento Therapeutics, Inc. | Phase 1 |
| Recruiting | Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer NCT06148298 | University of Central Florida | — |
| Unknown | A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors NCT05830097 | Coherent Biopharma (Hefei) Co., Ltd. | Phase 1 / Phase 2 |
| Unknown | A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas NCT05566743 | Menoufia University | Phase 2 |
| Active Not Recruiting | A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation NCT05485974 | HUYABIO International, LLC. | Phase 1 |
| Completed | Lidocaine Infusion With ERAS Protocol for Pancreatic Cancer Surgery: Effect on Pain and Patient Immunity. NCT05470166 | Alexandria University | N/A |
| Terminated | NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid NCT05252390 | Nuvation Bio Inc. | Phase 1 |
| Recruiting | Iconographic Registry of Pancreatobiliary Endoscopy Procedures NCT06344507 | IRCCS San Raffaele | — |
| Completed | Home-based Prehabilitation in Pancreatic Resection NCT05496777 | Nicole Hildebrand | N/A |
| Active Not Recruiting | A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations NCT05163028 | HUYABIO International, LLC. | Phase 1 |
| Unknown | Multi-omics Characterization of Pancreatic Neuroendocrine Tumors and Carcinomas NCT05234450 | University Hospital, Strasbourg, France | — |
| Recruiting | Echo-endoscopy Biopsy Impact on the Circulating Tumor Cell Level NCT04677244 | Institut Paoli-Calmettes | N/A |
| Active Not Recruiting | Onco-primary Care Networking to Support TEAM-based Care NCT04258813 | Duke University | N/A |
| Unknown | Pancreatico Enteric Anastomosis Post Pancreaticoduodenectomy NCT05163977 | Cairo University | N/A |
| Completed | The Registry of Oncology Outcomes Associated With Testing and Treatment NCT04028479 | Taproot Health | — |
| Completed | Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN) NCT04769414 | Menoufia University | Phase 2 |
| Unknown | Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer NCT04128332 | CCTU- Cancer Theme | N/A |
| Unknown | EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy NCT04809935 | The University of Hong Kong | Phase 4 |
| Completed | Permanent Celiac Plexus Block: Comparison of Pain Score in Unilateral and Bilateral Posterior Percutaneous App NCT06316908 | Sindh Institute of Urology and Transplantation | Phase 4 |
| Withdrawn | A Pilot Study of BXCL701 in Patients With Pancreatic Cancer NCT04123574 | BioXcel Therapeutics Inc | EARLY_Phase 1 |
| Unknown | The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly NCT04164602 | University of Pecs | — |
| Completed | Daily Imaging, Target Identification, and Simulated Computed Tomography-Based Stereotactic Adaptive Radiothera NCT04008537 | Washington University School of Medicine | N/A |
| Unknown | Heterotopic Ossification in Abdominal Incision and Pancreatic Cancer NCT04049461 | Nanjing Medical University | — |
| Recruiting | Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer NCT03977233 | UNC Lineberger Comprehensive Cancer Center | Phase 2 |
| Unknown | Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients NCT03924466 | Universitair Ziekenhuis Brussel | Phase 2 |
| Unknown | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor NCT03896958 | SpeciCare | — |
| Completed | Evaluation of the FOCUS Diffusion's Added Clinical Value Compared to Conventional MRI NCT03961646 | Fondation Hôpital Saint-Joseph | — |
| Unknown | A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Mali NCT03607643 | Leaf Vertical Inc. | Phase 1 / Phase 2 |
| Terminated | Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer NCT03649321 | University of Texas Southwestern Medical Center | Phase 1 / Phase 2 |
| Completed | Early Support in Primary Care for People Starting Treatment for Cancer NCT03719716 | NHS Lothian | N/A |
| Completed | A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) NCT02905578 | Joseph J. Cullen | Phase 2 |
| Recruiting | Tumour Regulatory Molecules in Early Pancreatic Cancer Detection NCT03536793 | Hull University Teaching Hospitals NHS Trust | — |
| Unknown | Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal Pancreatectomy NCT03659292 | Fudan University | N/A |
| Terminated | M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma NCT03451773 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Terminated | Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma NCT03822936 | CNAO National Center of Oncological Hadrontherapy | Phase 2 |
| Recruiting | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774 | Massive Bio, Inc. | — |
| Unknown | Effects of Epidural Anesthesia and Analgesia on the Prognosis in Patients Undergoing Pancreatic Cancer Surgery NCT03245346 | Fudan University | N/A |
| Active Not Recruiting | Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer NCT03347162 | Rigshospitalet, Denmark | — |
| Unknown | Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operat NCT03278015 | Chinese PLA General Hospital | Phase 2 |
| Terminated | Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer NCT02902484 | University of Texas Southwestern Medical Center | Phase 1 / Phase 2 |
| Completed | Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) NCT03133286 | DxTerity Diagnostics | — |
| Completed | Clinical Phase II Clinical Study Evaluating the Toxicity and Efficacy of mFOLFIRINOX Associated With SBRT (Ste NCT03891472 | Medical University of Silesia | Phase 2 |
| Completed | Enteral Nutrition After Pancreaticoduodenectomy NCT03150615 | Nanjing Medical University | N/A |
| Terminated | Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer NCT02681601 | Jonsson Comprehensive Cancer Center | N/A |
| Completed | Epidural Analgesia Use in Pancreatic Resections NCT02681796 | Washington University School of Medicine | Phase 1 |
| Terminated | BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer NCT02608229 | Washington University School of Medicine | Phase 1 |
| Completed | Improving Goals of Care Discussion in Advanced Cancer Patients NCT02374255 | Icahn School of Medicine at Mount Sinai | N/A |
| Unknown | Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas NCT02682394 | Soroka University Medical Center | — |
| Terminated | Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma NCT02352831 | Washington University School of Medicine | Phase 1 / Phase 2 |
| Completed | Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients NCT02311361 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Terminated | Acupuncture for Pain Control in Patients With Inoperable Pancreatic Cancer NCT02333409 | Chinese University of Hong Kong | N/A |
| Completed | Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimi NCT04971304 | Catherine M. Lockhart | — |
| Unknown | Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable L NCT02311439 | Assiut University | Phase 2 / Phase 3 |
| Completed | The Pre-operative Pathway in Pancreatic Head Malignancy-assessment of the Diagnostic Accuracy of Staging CT Sc NCT02296736 | University Hospital Plymouth NHS Trust | — |
| Completed | Effects of Dexmedetomidine During IRE Procedures for Solid Tumours NCT02044224 | Uppsala University Hospital | Phase 4 |
| Completed | A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients NCT02442323 | Fox Chase Cancer Center | N/A |
| Completed | Trial Comparing 19 and 25-gauge EUS-FNA Needles NCT01677312 | AdventHealth | N/A |
| Completed | Postoperative Stress Response in Patients Following Fast Track vs Conventional Protocol After Hepatectomy or P NCT02524925 | National and Kapodistrian University of Athens | N/A |
| Completed | Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic C NCT01446458 | Emory University | Phase 1 |
| Completed | Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer) NCT01420874 | Barbara Ann Karmanos Cancer Institute | Phase 1 |
| Completed | QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas NCT01231347 | NantCell, Inc. | Phase 3 |
| Terminated | Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Surviva NCT00613730 | Amgen | Phase 2 |